Skip to main navigation
Scientists Patients Medical Professionals Investors and Media Careers
 logo
  • News
  • Events
  • Stock
  • Financials
  • Governance
  • FAQs
    • Scientists
    • Patients
    • Medical Professionals
    • Investors and Media
    • Careers

INVESTORS & MEDIA

Financial Information

Financial Information
SEC Filings
Annual Reports and Proxy Statements
Quarterly Results

Q4 2022

  • Regeneron Reports Fourth Quarter and Full Year 2022 Financial and Operating Results
  • Regeneron Corporate Presentation February 2023 2.6 MB
  • Q4 2022 Earnings Conference Call Transcript 985.7 KB
  • Form 10-K
Annual Reports
Date Title
2021 Annual Report
2021 Annual Report 5.5 MB
Proxy Statements
Date Title
2022 Proxy Statement
2022 Proxy Statement 7.4 MB

Form 10-K

Filing date View
Feb 06, 2023 View HTML
0001804220-23-000008.pdf
0001804220-23-000008.xls
EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
Feb 07, 2022 View HTML
0001804220-22-000007.pdf
0001804220-22-000007.xls
EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA

Form 10-Q

Filing date View
Nov 03, 2022 View HTML
0001804220-22-000031.pdf
0001804220-22-000031.xls
EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
Aug 03, 2022 View HTML
0001804220-22-000023.pdf
0001804220-22-000023.xls
EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA

Interactive Analyst Center

Interactive and downloadable financial data for investors and analysts

View Analyst Center
Email Alerts
RSS Newsfeed
Share This Page
Search
Regeneron logo
  • Twitter logo
  • LinkedIn logo
  • Facebook logo
  • Instagram logo
  • YouTube logo
  • Terms of Use
  • Contact Us
  • Site Map
  • Social Media Terms of Engagement
  • Privacy Notice
  • Accessibility Statement
  • Investors and Media
  • Careers
  • Ireland
  • Covid-19 Antibody Program

Copyright © 2023 Regeneron Pharmaceuticals Inc. All rights reserved. All trademarks mentioned are the property of their respective owners.

Back to top

Investors & Media

  • Facebook
  • LinkedIn
  • Twitter
  • RSS Feeds

You are now leaving Regeneron.com. The site you are about to visit is maintained by a third party who is solely responsible for its content. We encourage you to read the privacy policy of every website you visit.

Continue

You are now leaving Regeneron.com to visit another Regeneron pharmaceuticals website.

Continue